Skip to main content
. 2025 Nov 28;22:145. doi: 10.1186/s12986-025-01041-9

Fig. 3.

Fig. 3

Decreased circulating PDI levels are associated with an increased risk of T2DM in MASLD patients. (A) Spearman correlation analysis between the plasma levels of PDI with the hepatic mRNA expression of PDI. (B) Plasma PDI levels in diabetic (n = 28) and nondiabetic (n = 35) subjects. Spearman correlation analysis between the plasma levels of PDI with (C) FBG and (D) HbA1c. (E) Adjusted ORs of diabetes according to tertiles of plasma PDI levels in patients. The ORs with corresponding 95% confidence intervals (CIs) were adjusted for age, sex and BMI. The tertile ranges of T1, T2 and T3 of the plasma PDI level were < 7.35, 7.35–9.86, and > 9.86 ng/ml, respectively. T1 is the reference group. A binary logistic regression study was applied. (F) ROC curves of classification of participants with and without T2D